By G HossainPosted on April 13, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The licensing deal marks AbbVie’s first foray into new pain medicines, a space where Vertex currently enjoys a lead thanks to the NaV1.8 inhibitor Journavx. AbbVie enters world of pain in up to $715M deal with China’s Haisco Post navigation Regeneron enters radiopharma ring with up to $4.3B Telix allianceUSP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns